skip to main content
Back to Top

Last updated July 7, 2021

The COVID-19 Resource Canada Site

Funding opportunities


Trans-Atlantic Platform (T-AP) for Social Sciences and Humanities

Intention to submit form to T-AP: June 14, 2021
Application deadline: July 12, 2021
Funding available: Maximum funding per proposal for SSHRC is $200,000 CAD. Each project should have a duration ranging between 24 and 36 months.

T-AP will support international projects that contribute to our understanding of the complex societal effects of the COVID-19 pandemic including reducing inequalities and vulnerabilities; building a more resilient, inclusive and sustainable society; fostering democratic governance and political participation; advancing responsible and inclusive digital innovation; and ensuring effective and accurate communication and media.

More information


Arthritis Society | Stars Career Development Award

Abstract registration deadline: May 26, 2021 5 p.m. ET
Application deadline: July 12, 2021 5 p.m. ET
Funding available: Up to $125,000 for up to three years ($375,000 total)

The Stars Career Development award has been created to firmly establish the career of early career investigators. This salary and research funding represents a three (3) year commitment by the Arthritis Society, together with an additional three (3) year commitment by the applicant’s Host Institution.  The program is intended to promote creativity in all domains of arthritis-related research responsive to the Arthritis Society’s strategic priorities.

More information


CIHR | Team Grant: Diabetes Mechanisms and Translational Solutions

Application deadline: July 13, 2021
Funding available: The maximum amount per grant is $400,000 per year for up to 5 years, for a total up to of $2,000,000 per grant.

As part of 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, the Team Grants in Diabetes Mechanisms and Translational Solutions will support multi-disciplinary research to better understand the underlying causes and pathophysiology of diabetes and develop improved prevention and treatment approaches for diabetes. For the purposes of this Initiative, diabetes includes all forms of diabetes mellitus, its complications, and co-morbidities. Mechanistic research is defined as studies designed to understand the pathophysiology of diabetes, its complications, and co-morbidities. Translational research is defined as research that advances effective translation and application of knowledge across the expanse of pre-clinical, clinical and health services delivery domains to improve patient outcomes.

More information


Ministry for Seniors and Accessibility | 2021-22 Seniors Community Grant Program

Application deadline: July 15, 2021, 5 p.m. ET
Funding available: Up to $25,000

The program will support projects that meet at least one of the following key priorities: Promote and support age-friendly community development; strengthen the safety and well-being of older adults; adapt and deliver programs and services to isolated older adults either virtually or in-person so they can stay active and socially engaged; and create safe opportunities for older adults to network and increase engagement in community labour markets through virtual mentoring, volunteerism, and training to support entrepreneurship.

Apply
More information


Department of Defense | Peer reviewed Alzheimer’s research program (PRARP) funding opportunities for fiscal year 2021

LOI deadline: June 14, 2021
Application deadline: July 21, 2021
Funding available: Variable – see call

The PRARP was initiated in 2011 to address the long-term consequences of TBI as they pertain to Alzheimer’s disease (AD). In 2016, the program was expanded to include AD-related dementias (ADRD) research as it pertains to TBI. In 2021, the program expanded its focus to include the spectrum of AD and ADRD risk factors that may affect military health. The program emphasizes not only basic research related to understanding and diagnosing the molecular basis of dementia after military service, but also tools and strategies which can improve the quality of life of individuals living with AD or ADRD by their implementation in care settings.

More information


Canadian Foundation for Dietetic Research

Competition opens: July 26, 2021
Letter of intent deadline: September 20, 2021
Invited proposal deadline: March 4, 2022
Funding available: $20,000

Priority research themes include: Practice-based challenges presented by the COVID-19 pandemic; outcomes of intervention: objective measures of the effect of a nutrition intervention in all practice area; expanding roles for dietitians in meeting health needs of all people living in Canada: education, training, implementation, and evaluation of novel service delivery; identification, assessment, and risk reduction strategies for groups at risk of nutritional vulnerability; determinants of food choice: identification of factors and attitudes that influence the food choices made by consumers.

More information


Alzheimer’s Drug Discovery Foundation-Harrington Scholar Program

LOI deadline: April 23, 2021, 5 p.m. ET
Proposal deadline: July 30, 2021, 5 p.m. ET
Funding available: $600,000 over two years

The ADDF-Harrington Scholar Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. This unique award provides funding and committed project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute.

More information


CIHR | Team grant: Healthy cities implementation science (HCIS) team grants

Letter of intent deadline: August 11, 2021
Application deadline: April 28, 2022
Funding available: Up to $27,450,000 (see call for more details)

The HCIS Team Grant funding opportunity will support one (1) research project in each of the six (6) thematic research areas. Therefore proposed research projects must be relevant to at least one thematic area but may also be relevant to multiple thematic areas: healthcare systems, services and policies; healthy aging; musculoskeletal health, mobility or prevention (including skin and oral health); type 2 diabetes prevention; urban Indigenous health; population and public health.

More information


NIH Department of Health and Human Services | Mechanism-focused research to promote adherence to healthful behaviors to prevent mild cognitive impairment (MCI) and Alzheimer’s disease and related dementias (AD/ADRD) (R01 clinical trial optional)

Letter of intent deadline: August 15, 2021; December 26, 2022
Application deadline: September 15, 2021; January 26, 2022
Funding available: $2,250,000 for four to six awards

This Funding Opportunity Announcement (FOA) invites R01 applications for ancillary studies that address psychological and interpersonal mechanisms driving adherence to behavior or lifestyle change relevant to the prevention of cognitive decline, Mild Cognitive Impairment (MCI), and Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Successful applications will seek to identify malleable, mechanistic, psychological, or interpersonal targets that – if modified – will strengthen adherence to, maintenance of, and continued/renewed engagement in behaviors that may promote cognitive health and prevent AD/ADRD.

This FOA will specifically support ancillary studies to ongoing, early- to late-stage clinical intervention trials. Ancillary studies should provide the opportunity to explore novel psychological and interpersonal mechanisms by collecting new data from participants enrolled in the ongoing parent study.

More information


NIH Department of Health and Human Services | Mechanism-focused research to promote adherence to healthful behaviors to prevent mild cognitive impairment (MCI) and Alzheimer’s disease and related dementias (AD/ADRD) (R61/R33 clinical trial required)

Letter of intent deadline: August 15, 2021
Application deadline: September 15, 2021
Funding available: $3,000,000 for six to eight awards

This Funding Opportunity Announcement invites R61/R33 applications to address psychological and interpersonal mechanisms driving adherence to behaviors or lifestyle changes relevant to prevention of cognitive decline, Mild Cognitive Impairment (MCI), and Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Mechanisms of adherence may be studied in new, early- to late-stage (including Stage I-IV) behavior change trials. Successful applications will seek to identify malleable, mechanistic, psychological, or interpersonal targets that, if modified, will strengthen adherence to, maintenance of, and continued/renewed engagement in behaviors that may promote cognitive health and prevent AD/ADRD. This FOA will support pilot research (R61) to identify, measure, and assess the malleability of psychological or interpersonal adherence-relevant targets that, if successful, can transition to an R33 phase for implementation of rigorous, proof-of-concept intervention studies.

More information


NSERC | Collaborative Research and Training Experience (CREATE)

Letter of intent deadline: May 1, 2021
Application deadline: September 22, 2021
Funding available: Up to $150,000 in the first year and up to $300,000 for up to five subsequent years, for a maximum of $1.65M over 6 years.

The CREATE program supports the training and mentoring of teams of highly qualified students and postdoctoral fellows from Canada and abroad through the development of innovative training programs that encourage collaborative and integrative approaches, and address significant scientific challenges associated with Canada’s research priorities and facilitate the transition of new researchers from trainees to productive employees in the Canadian workforce. These innovative programs must foster the acquisition and development of important professional skills among students and postdoctoral fellows that complement their qualifications and technical skills, and improve their job readiness for careers in industry, government, non-governmental organizations and/or academia.

More information


Velux Stiftung | Healthy aging and daylight research

Application deadline: September 30, 2021
Funding available: $68,000 to $136,000 CDN

You have an innovative idea for a research project in one of our funding areas. You aim to create impact with your research results that transfer beyond the borders of a single discipline. You identify with the aims of the foundation and want to foster its purpose. Then we might be the right partner for you and you should consider applying to us. The foundation welcomes international and interdisciplinary collaborations. The approved amount will be paid out to the principle investigator’s institution which is responsible to distribute the funds to collaborators and compile the necessary reports. If your project has an interdisciplinary approach that involves several of our funding areas, we ask you to define the main funding area. The main funding area is defined by where your project results will contribute to change. Fields of study are use of natural daylight and its effects on humans and nature or healthy aging.

More information


Alzheimer’s Drug Discovery Foundation Neuroimaging and CSF Biomarker Development Program

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: $600,000 over 1 year (multi year proposals considered)

The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Specifically, this RFP focuses on developing novel PET ligands for clinical trials, supporting novel CSF biomarkers, validating established MRI approaches in larger cohorts.

More information


Alzheimer’s Drug Discovery Foundation Drug Development Program

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: Up to $600,000 based on stage and scope of research, per year. One year with potential for follow-on funding. Multi-year proposals can be considered.

The Drug Development RFP seeks to support in vivo preclinical studies that advance lead molecules developed for Alzheimer’s disease and related dementias to IND-enabling studies. The proposed studies should be structured to deliver a compound with strong potential for clinical and commercial application. This funding opportunity prioritizes novel drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP. 

More information


Alzheimer’s Drug Discovery Foundation Program to Accelerate Clinical Trials (PACT)

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: Up to $3,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment. Average duration multi-year, with potential for follow-on funding.

The PACT RFP supports IND-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias. Both disease-modifying and symptomatic agents will be considered. This funding opportunity prioritizes diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP. 

More information


Alzheimer's Drug Discovery Foundation Prevention Pipeline

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: $3,000,000 (multi year proposal)

The Alzheimer’s Drug Discovery Foundation seeks to support studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. The Prevention Pipeline supports: studies of cognitive decline and risk reduction, comparative effectiveness research, studies leveraging the consortium of cohorts for Alzheimer's prevention action.

More information


Canadian Institutes of Health Research | The Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging

Application deadline: October 5, 2021
Funding available: $200,000 per year for up to five years

Brain health issues related to aging are a major health concern. Women generally live longer than men yet they experience a heavier burden of chronic disease. Seventy percent (70%) of people affected by Alzheimer’s disease are women. As such, research into the sex and gender differences affecting brain health is needed to facilitate the discovery of key findings that can be used to improve women’s brain health. The Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging is an integrated initiative within CIHR’s Dementia Research Strategy. The Strategy supports research on the latest preventive, diagnostic and treatment approaches to Alzheimer's disease and related dementia. The Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging initiative will help augment the impact of research in this area. The Chair is designed to contribute to the salary and provide support to the Chair holder in their implementation of the Chair program. The Chair research allowance is for strategic activities, including trainee support, mentoring, and knowledge mobilization activities.

More information


CIHR Institute of Aging| Planning and Dissemination Grants

Application deadline: December 13, 2021
Funding available: The maximum amount awarded for a single grant is $25,000.

More information


Birks Family Foundation Grant

Application deadline: Rolling (apply six months prior to when funds would be required) 
Funding available: Application dependent

The Birks Family Foundation funds organizations either primarily focused on Quebec, or those whose work is broadly national in nature; Public sector organizations, including universities, hospitals, libraries and museums; Projects that demonstrate unique innovation in their field and/or pioneer state-of-the-art technology; Long range projects designed to become self-sustaining; and, organizations that actively engage directly with their target group through programs and/or services. 

More information


Max Bell Foundation Grant

Application deadline: Rolling
Funding details: Apply for the amount of money that you need to complete your project. Be aware that Max Bell Foundations generally funds 30-60% of a project and prefers to fund projects that have other funders.

The foundation prefers to collaborate with applicants to create final project proposals. Proposals should focus on development of forward-looking innovations that impact public policies and practices with an emphasis on health and wellness, education, and the environment.

More information


NSERC Alliance

Application deadline: applications are currently being accepted for Option 1 and 2
Funding available: $20,000 to $1,000,000 per year for one to five years

NSERC Alliance grants encourage university researchers to collaborate with partner organizations, which can be from the private, public or not-for-profit sectors. Funding may support research and development projects that seek to respond to a research challenge in the natural sciences or engineering, while working with external partners who are able to accelerate scale-up, application, impact, or commercialization. NSERC is now accepting Option 1 applications requiring at least 50 per cent matching cash contributions from partner organizations, and for Option 2, involving non-profit partners and requesting 90 to 100 per cent funding support from NSERC.

More information


Physician’s Services Incorporated (PSI) Foundation 

Clinical Research Grant

The PSI Clinical Research Grant is open to Post M.D. physicians looking to conduct research which is of direct relevance to patient care.

More information

Health Systems Research Grant

The Health Systems research grant funds projects of a special nature within the healthcare system, such as preventative medicine, care of the elderly, communications within the system, underserviced regions, and ways of enhancing the effectiveness of medical practice will be considered under this category. 

More information

New Investigator Research Grant 

The New Investigator funding stream is open to Clinical Fellows or physicians within five years of their first academic appointment. 

More information

Resident Research Grant 

Resident Research Grants are concise health research projects, which have been largely developed by the Resident. To be eligible to apply for a Resident Research Grant, the Resident must have PGY status as per the College of Physicians and Surgeons of Ontario. The restriction whereby PSI will not consider applications for research within the areas of cancer, and heart and stroke does not apply to resident research projects.

More information

Healthcare Research by Community Physicians Grant 

To assist physicians practicing in a community setting to undertake a review of their practice patterns which would enhance effectiveness of practice and patient care in their own clinic, hospital, or region.

More information

Graham Farquharson Knowledge Translation Fellowship 

The PSI Graham Farquharson Fellowship is intended to provide salary support for a new investigator who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research.

More information

 
 
Email MIRA at: MIRAinfo@mcmaster.ca       Follow us on Twitter : @MIRAMcMaster
McMaster Footer Logo
Institute For Research On Aging Footer Logo

© 201​6 McMaster University  |  MIP Suite 109A, 1280 Main St. W., Hamilton, ON L8S 4K1  |  Contact Us  | Email UsTerms of Use & Privacy Policy